'She treats my sibling and me as virtual strangers' ...

Wall Street Is Sounding the Alarm on U.S. Debt. This Time, It's Worth Listening. "You are going to see a crack in the bond market," warns Jamie Dimon. He has plenty of company. Consumer prices were ...

British American Tobacco Raises Outlook on Better-Than-Expected Revenue BAT expects the U.S. to return to revenue and profit growth, driven by strengthening delivery in the combustibles category and ...

While the Paris-based OECD has trimmed global growth estimates for 2025 and 2026 to 2.9%, versus 3.1% and 3% previously, the change to its U.S. outlook was more draconian. Growth for 2025 was slashed ...

Meta (META) shares were slightly down on Tuesday morning before the market open. Constellation shares are up 40% so far this year. While the company is an energy supplier more broadly, its stock has ...

The S&P 500 SPX is only 3.78% off its February highs, after May's record gains, though it remains to be seen if the rally will keep going through the long days of summer. That's as other segments of ...

The updated guidance assumes that Dollar General will be able to mitigate "a significant portion of the potential impact to its cost of goods from tariffs at currently implemented rates," the company ...

The Chinese automaker said Tuesday that its net loss was 6.89 billion yuan, equivalent to $957 million, widening from 5.26 billion yuan a year earlier. Revenue rose 21% to 12.03 billion yuan. Analysts ...

The nearly century-old Japanese company that founded Toyota Motor in the 1930s plans to go private in a deal that values the now-forklift maker at about $34 billion, with backing from the car giant's ...

Our fair value estimate for Treasury Wine Estates is AUD 12 per share. We assign Treasury a 9% cost of equity, and along with our assumed 6.5% long-term cost of debt, our approximate weighted average ...

Although some may hate to admit it, social media influencers focused on financial topics—or “finfluencers”—have become a ...

Beam Therapeutics' investigational modified cell therapy for treating sickle-cell disease has been granted orphan-drug status by the Food and Drug Administration.